Global Heart Valve Devices Market Draws Growth from Increasing Instances of Obesity and Unhealthy Lifestyles Causing Cardiac Diseases

The global heart valve devices market is prophesied to aim higher in terms of growth due to rising instances of unhealthy lifestyles and obesity leading to a number of pathological disorders and cardiac diseases. The market could be positively impacted with the introduction of new and effective devices facilitated by recent technological advancements. The latest developments in technology are also anticipated to set the tone for persistent product modifications and a swelling demand for minimally invasive procedures.

Transparency Market Research (TMR) envisages the global heart valve devices market to expand at a 12.4% CAGR between 2017 and 2025 to be valued at a US$16.2 bn by the completion of the final forecast year. In 2016, the market was valued at a US$5.8 bn.

A new adjustable heart valve replacement device has been successfully implanted in a patient for the first time by Kephalios. The implant was made during a clinical trial at the Vienna General Hospital to repair mitral valve regurgitation. The French company has taken inspiration from mitral valve annuloplasty to develop the device.

How would Uptake of Technologically Superior Products Impact Sales?

Various types of heart valve devices including transcatheter, biological, and mechanical heart valves are expected to showcase their prominence in the coming years. However, some of them could outshine with their higher revenues and growth rates, thus attracting the focus of players operating in the world heart valve devices market. A maximum amount of market share is predicted to be achieved by transcatheter heart valve devices owing to a strong support gained from the considerably lower mortality rate achieved. Yet, there could be more factors augmenting the demand for transcatheter heart valves in the market: more than average selling prices and increasing uptake of technologically advanced products in developed economies.

Biological heart valves are foreseen to attain growth at a healthy rate during the forecast tenure. However, the threat of substitutes could slow down their growth in the foreseeable future. This is forecast to be due to the advent of novel technologies such as heart valves manufactured with the use of bioabsorbable polymer scaffolds providing therapeutic healing.


What Factors could Help North America to Surpass Other Regions?

From a regional perspective, the international heart valve devices market is envisaged to witness the lead taken by North America on the back of powerful growth factors such as greater average selling prices of products. Players concentrating on the growth in this region could also take advantage of the impressive adoption of technologically sophisticated techniques. The region is prognosticated to be valued at a US$6.92 bn by the end of the forecast tenure.

With regard to market share, North America could be followed by Europe riding on an enormous pool of geriatrics increasingly vulnerable to different heart disorders. Apart from this, the region is envisioned to rest its hopes on supportive government policies and several product launches. On the other hand, Asia Pacific could leverage opportunities birthing on account of improving healthcare infrastructure and swelling occurrence of cardiovascular diseases.

The presence of numerous companies is expected to render a fragmented nature for the worldwide heart valve devices market. Companies could focus on product innovation and the expansion of product portfolio to secure a strong position in the market.

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports